{"SPADE_UN_28502": {"Sequence Information": {"Peptide Name": "", "Sequence": "GXRKXKAXWH", "Sequence Length": 10, "Biological Activity": ["Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.", "Pubmed ID": "20176897", "Reference": "Antimicrob Agents Chemother. 2010;54:1693-1699", "Author": "Anantharaman A, Rizvi MS, Sahal D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/20176897"}], "SPADE ID": "SPADE_UN_28502", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02394", "Similarity": 1.0, "Sequence": "AHCLAIGRK"}, {"SPADE_ID": "SPADE_N_07921", "Similarity": 1.0, "Sequence": "MASSFMFAVVVLFISLAANVESYLAFRCGRYSPCLDDGPNVNLYSCCSFYNCHKCLARLENCPKGLHYNAYLKVCDWPSKAGCTSVNKECHLWKTGRK"}, {"SPADE_ID": "SPADE_N_11828", "Similarity": 1.0, "Sequence": "AAHCLAIGRK"}], "Hemolytic Activity": "Human erythrocytes:-=NA", "Target Organism": "Escherichia coli ML-35p(MIC=67.9Âµg/ml),Mouse fibrosarcoma L929(no activity data),Human cervical carcinoma HeLa(no activity data)"}}}